期刊文献+

股骨头缺血性坏死中双膦酸盐的应用 被引量:3

Application of bisphosphonates in avascular necrosis of the femoral head
下载PDF
导出
摘要 背景:实验显示双膦酸盐对预防股骨头塌陷起到积极作用,但临床应用结果存在一定争议,且由于系统用药的不良反应较多,近期对局部应用的研究逐渐增多。目的:综述双膦酸盐治疗股骨头缺血性坏死的研究进展。方法:由2位共同第一作者检索PubMed数据库及CNKI中国期刊全文数据库收录的双膦酸盐治疗股骨头缺血性坏死的相关文章,英文检索词为"osteonecrosis of the femoral head,bisphosphonates,systemic therapy,topical therapy,osteogenesis,bone destruction,bone remodeling",中文检索词为"股骨头坏死、双膦酸盐、系统、局部、成骨、破骨、骨重塑",按纳入和排除标准共纳入文献62篇进行归纳总结。结果与结论:双膦酸盐对成骨细胞既有抑制作用也有激活作用,目前存在一定争议。目前研究显示低浓度双膦酸盐可促进成骨细胞的增殖,而高浓度起到抑制作用。长期系统应用双膦酸盐会有下颌骨坏死等不良反应,而局部应用双膦酸盐治疗股骨头缺血性坏死仍停留在实验阶段,且治疗股骨头缺血性坏死的最佳浓度及药效持续时间都尚未确定,在临床应用前仍需进一步的高质量实验研究来阐明。 BACKGROUND:Animal experiments have shown that bisphosphonates exhibit a preventive effect on femoral head collapse.However,clinical application of bisphosphonates remains disputed.Systematic administration of bisphosphonates has many adverse reactions.There is an increasing number of studies on local application of bisphosphonates.OBJECTIVE:To review the research progress of bisphosphonates in the treatment of avascular necrosis of the femoral head.METHODS:The first authors(GJC and MJH) searched PubMed and CNKI databases to retrieve papers regarding bisphosphonate treatment of osteonecrosis of the femoral head using the search terms "osteonecrosis of the femoral head,bisphosphonates,systemic therapy,topical therapy,osteogenesis,bone destruction,bone remodeling" in English and Chinese.Sixty-two eligible papers were included in the final analysis.RESULTS AND CONCLUSION:It remains disputed whether bisphosphonates inhibit or activate osteoblasts.Current studies have shown that low concentration of bisphosphonates can promote the proliferation of osteoblasts,while high concentration of bisphosphonates can inhibit the proliferation of osteoblasts.Long term systematic application of bisphosphonates can induce mandibular osteonecrosis and other side effects.Topical application of bisphosphonates for treatment of avascular necrosis of the femoral head is still in the experimental stage.The optimal bisphosphonate concentration and the duration of efficacy in the treatment of avascular necrosis of the femoral head have not been determined.These should be clarified by in-depth high-guality experiments prior to clinical application.
作者 葛均成 马金辉 王佰亮 岳德波 孙伟 王卫国 郭万首 李子荣 Ge Juncheng;Ma Jinhui;Wang Bailiang;Yue Debo;Sun Wei;Wang Weiguo;Guo Wanshou;Li Zirong(Sino-Japan Friendship Hospital,Peking University,Beijing 100020,China;First Department of Orthopedics,Sino-Japan Friendship Hospital,Beijing 100020,China)
出处 《中国组织工程研究》 CAS 北大核心 2020年第5期753-759,共7页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金项目(81772350),项目负责人:王佰亮 中日友好医院院内课题(2018-1-QN-9),项目负责人:马金辉~~
关键词 股骨头缺血性坏死 双膦酸盐 系统用药 局部用药 成骨细胞 破骨细胞 骨重塑 非创伤性股骨头缺血性坏死 avascular necrosis of the femoral head bisphosphonate systemic administration topical administration osteoblasts osteoclasts bone remodeling non-traumatic avascular necrosis of the femoral head
  • 相关文献

参考文献3

二级参考文献33

  • 1Mont MA, Zywiel MG, Marker DR,et al. The natural history of un- treated asymptomatic osteonecrosis of the femoral head : a systematic literature review [ J ]. J Bone Joint Surg Am,2010,12:2165 - 2170.
  • 2Fleisch H, Russell RG, Francis MD. Diphosphonates inhibit hydroxyap- atite dissolution in vitro and bone resorption in tissue culture and in vivo [ J ]. Science, 1969,3899 : 1262 - 1264.
  • 3Russell RG. Bisphosphonates : the first 40 years [ J ]. Bone,2011,1 : 2 -19.
  • 4Soe K, Delaiss6 JM. Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle [ J ]. J Bone Miner Res, 2010,10:2184 - 2192.
  • 5Rogers M J, Gordon S, Benford HL, et al. Cellular and molecular mechanisms of action of bisphosphonates [ J ]. Cancer,2000,12:2961 - 2978.
  • 6Rogers M J, Crockett JC, Coxon FP, et al. Biochemical and molecu- lar mechanisms of action of bisphosphonates[ J. Bone, 2011,1:34 -41.
  • 7Ohe JY, Kwon YD, Lee HW. Bisphosphonates modulate the expres-sion of OPG and M - CSF in hMSC - derived osteoblasts [ J ]. Clin O- ral Investig,2012,4 : 1153 - 1159.
  • 8Tsubaki M, Satan T, Itoh T, et al. Bisphosphonate - and statin - in- duced enhancement of OPG expression and inhibition of CD9, M - CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2 [ J]. Mol Cell Endocrinol,2012,1 -2:219 -231.
  • 9Sakai H, Chen Y, Itokawa T. Activated c - Fms recruits Vav and Rac during CSF - 1 - induced cytoskeletal remodeling and spreading in osteoclasts [ J]. Bone ,2006,6 : 1290 - 1301.
  • 10Plotkin LI, Bivi N, Bellido T. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice[ J]. Bone ,2011,1 : 122 - 127.

共引文献21

同被引文献80

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部